Pediatric oncology sedation trial (POST): A double-blind randomized study

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 634-638

  Nagel, Kim ^a   Willan, Andrew R ^b   Lappan, Janie ^a   Korz, Linda ^c,d   Buckley, Norman ^c,d   Barr, Ronald D ^a,d  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Double blind; Oncology; Pediatric; Randomized; Sedation

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; FENTANYL; MIDAZOLAM; ONDANSETRON; PLACEBO; PROPOFOL; SEDATIVE AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LUMBAR PUNCTURE; MAINTENANCE THERAPY; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETCHING; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEDATION; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ANTIEMETICS; ANTINEOPLASTIC AGENTS; BIOPSY, NEEDLE; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; CONSCIOUS SEDATION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, SPINAL; MALE; MIDAZOLAM; ONDANSETRON; PAIN; POSTOPERATIVE NAUSEA AND VOMITING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPOFOL; SPINAL PUNCTURE;

EID: 52249089977     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21669     Document Type: Article

References (14)

1. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Philadephia: Lippincott Williams and Wilkins; 2006. pp. 538-590.
2. American College of Emergency Physicians. Clinical policy for procedural sedation and analgesia in the emergency department. Ann Emerg Med 1998;31:663-677.
3. Mace SE, Barata IA, Cravero JT, et al. The EMSC Grant Panel Writing Committee. Clinical policy: Evidence-based approach to pharmacologic agents used in pediatric sedation and analgesia in the Emergency Department. J Emerg Nurs 2004;30:447-461.
4. Whaley L, Wong O. Faces pain rating scale. St. Louis: C.V. Mosby Company; 1987. p. 1070.
5. American Academy of Pediatrics, Committee on Drugs, Section of Anesthesiology. Pediatrics 1985;76:317-321.
6. Committee on Drugs. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992;89:1110-1115.
7. Krauss B, Green SM. Primary care: Sedation and analgesia for procedures in children. N Eng J Med 2000;342:938-945.
8. Jayabose S, Levendoglu-Tugal O, Giamelli J, et al. Intravenous anesthesia with propofol for painful procedures in children with cancer. J Pediatr Hematol Oncol 2001;23:290-293.
9. Larsson S, Argeirsson B, Magnusson J. Propofol-fentanyl anesthesia compared to thiopental-halothane with special reference to recovery and vomiting after pediatric strabismus surgery. Acta Anaesthsiol Scand 1992;36:182-186.
10. Martin TM, Nicholson SC, Bargas MS. Propofol anesthesia reduces emesis and airway obstruction in pediatric outpatients. AnesthAnalg 1993;76:144-148.
11. McDowall RH, Scher CS, Barst SM. Total intravenous anesthesia for children undergoing brief diagnostic or therapeutic procedures. J Clin Anesth 1995;7:273-280.
12. Holdsworth MT, Raisch DW, Winter SS, et al. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer 1998;6:132-138.
13. White PF. Prevention of postoperative nausea and vomiting: A multimodal solution to a persistent problem. N Eng J Med 2004;350:2511-2512.
14. Parker RI, Prakash D, Mahan RA, et al. Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. J Pediatr Hematol Oncol 2001;23:578-581.